Intensive tailored telehealth management (ITTM) for Secondary Hypertension

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Secondary HypertensionIntensive Clinic Management (ICM) - Behavioral
Eligibility
18 - 75
All Sexes
What conditions do you have?
Select

Study Summary

TEAMS-BP is a multicenter, participant-randomized controlled trial designed to compare the effectiveness of Intensive Tailored Telehealth Monitoring (ITTM) versus Intensive Clinic Management (ICM) on Blood Pressure (BP) control and patient activation for BP management following stroke

Eligible Conditions
  • Secondary Hypertension

Treatment Effectiveness

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: 3 Month

3 Month
Proportion of participants eligible among those screened
3 months
Proportion of participants attending both visits among those who are randomized in the study
Proportion of participants billed
Proportion of participants with 3-month SBP control
Proportion of respondents with top score in overall experience on the Research Participant Perception Survey (RPPS)
Systolic Blood Pressure Mean Value
Baseline
Proportion of participants providing written informed consent among those eligible
Baseline, 3 month
Mean change in Partners in Health Scale (PIH) score at 3 months
Mean change in systolic blood pressure (SBP) at 3 months

Trial Safety

Trial Design

2 Treatment Groups

Intensive tailored telehealth management (ITTM)
1 of 2
Intensive Clinic Management (ICM)
1 of 2

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Intensive tailored telehealth management (ITTM) · No Placebo Group · N/A

Intensive tailored telehealth management (ITTM)
Behavioral
Experimental Group · 1 Intervention: Intensive tailored telehealth management (ITTM) · Intervention Types: Behavioral
Intensive Clinic Management (ICM)
Behavioral
Experimental Group · 1 Intervention: Intensive Clinic Management (ICM) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 month

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,124 Previous Clinical Trials
1,127,092 Total Patients Enrolled
Cheryl Bushnell, MDPrincipal InvestigatorWake Forest Health Sciences
3 Previous Clinical Trials
155 Total Patients Enrolled

Eligibility Criteria

Age 18 - 75 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have access to a smartphone or tablet with broadband access.
You agree to participate in either intervention to which you are assigned and attend all required study visits.